Abstract

Amino acids and more precisely, branched-chain amino acids (BCAAs), are usually consumed as nutritional supplements by many athletes and people involved in regular and moderate physical activities regardless of their practice level. BCAAs have been initially shown to increase muscle mass and have also been implicated in the limitation of structural and metabolic alterations associated with exercise damage. This systematic review provides a comprehensive analysis of the literature regarding the beneficial effects of BCAAs supplementation within the context of exercise-induced muscle damage or muscle injury. The potential benefit of a BCAAs supplementation was also analyzed according to the supplementation strategy—amount of BCAAs, frequency and duration of the supplementation—and the extent of muscle damage. The review protocol was registered prospectively with Prospective Register for Systematic Reviews (registration number CRD42017073006) and followed Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. Literature search was performed from the date of commencement until August 2017 using four online databases (Medline, Cochrane library, Web of science and ScienceDirect). Original research articles: (i) written in English; (ii) describing experiments performed in Humans who received at least one oral BCAAs supplementation composed of leucine, isoleucine and valine mixture only as a nutritional strategy and (iii) reporting a follow-up of at least one day after exercise-induced muscle damage, were included in the systematic review analysis. Quality assessment was undertaken independently using the Quality Criteria Checklist for Primary Research. Changes in indirect markers of muscle damage were considered as primary outcome measures. Secondary outcome measures were the extent of change in indirect markers of muscle damage. In total, 11 studies were included in the analysis. A high heterogeneity was found regarding the different outcomes of these studies. The risk of bias was moderate considering the quality ratings were positive for six and neutral for three. Although a small number of studies were included, BCAAs supplementation can be efficacious on outcomes of exercise-induced muscle damage, as long as the extent of muscle damage was low-to-moderate, the supplementation strategy combined a high daily BCAAs intake (>200 mg kg−1 day−1) for a long period of time (>10 days); it was especially effective if taken prior to the damaging exercise.

Highlights

  • In a recent report entitled “Protein Ingredients Market by Source (Animal and Plant), Application (Food & Beverage, Animal Feed, Cosmetics & Personal Care and Pharmaceuticals), and Region—Nutrients 2017, 9, 1047; doi:10.3390/nu9101047 www.mdpi.com/journal/nutrientsForecast to 2022”, the market for protein ingredients was projected to reach 58.49 billion dollars by 2022(i.e., compound annual growth rate of 6.0% from 2017)

  • Articles and studies were included if they met all the following criteria: (1) experiments performed in humans; (2) healthy subjects received at least one oral branched-chain amino acids (BCAAs) supplementation as a nutritional strategy in the context of skeletal muscle damage; (3) supplementation only composed of leucine, isoleucine and valine; (4) follow up performed at least one day after exercise-induced muscle damage or muscle injury; (5) original research articles; and (6) written in English

  • Throughout this systematic review, we identified that BCAAs can alleviate outcomes of Exercise-induced muscle damage (EIMD) for specific conditions regarding the extent of muscle damage and the supplementation strategy

Read more

Summary

Introduction

In a recent report entitled “Protein Ingredients Market by Source (Animal and Plant), Application (Food & Beverage, Animal Feed, Cosmetics & Personal Care and Pharmaceuticals), and Region—Nutrients 2017, 9, 1047; doi:10.3390/nu9101047 www.mdpi.com/journal/nutrientsForecast to 2022”, the market for protein ingredients was projected to reach 58.49 billion dollars by 2022(i.e., compound annual growth rate of 6.0% from 2017). BCAAs are important precursors of tricarboxylic acid (TCA) cycle intermediates via acetyl-CoA and Succinyl-CoA [7] and can be involved in energy production through the modulation of exercise-induced serum BCAAs oxidation [8]. In addition to their involvement as constitutive elements of the structural and contractile proteins synthesis [9], BCAAs are considered signaling molecules [10]. BCAAs and especially leucine have been reported to activate the mammalian target of rapamycin signaling pathway [11,12], thereby promoting muscle-protein synthesis [13,14,15]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call